The PLA General Hospital
Welcome,         Profile    Billing    Logout  
 11 Trials 
9 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chen, Yundai
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Active, not recruiting
N/A
539
RoW
BuMA Supreme, BuMA™
Sino Medical Sciences Technology Inc.
Coronary Artery Disease
03/18
12/25
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Active, not recruiting
N/A
1000
RoW
BuMA Supreme
Sino Medical Sciences Technology Inc.
Coronary Artery Disease
05/19
12/25
NCT03574636: OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation

Recruiting
N/A
375
RoW
OCT guidance, IVUS guidance, QCA
Shanghai MicroPort Medical (Group) Co., Ltd.
Optical Coherence Tomography, Intravascular Ultrasound, Angiography
09/21
09/25
SUPERIOR, NCT04617899: The StUdy to Evaluate the Performance and safEty of the Novasight HybRid System Using Objective PeRformance Criteria

Recruiting
N/A
120
RoW
Intravascular imaging
CardioNavi MedTech (Wuhan) Co., Ltd., Beijing Jingruitianhe Medical Science and Technology Development Co,Ltd
Coronary Artery Disease
11/21
12/21
NCT04733443: The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis

Active, not recruiting
N/A
310
RoW
Biolimus, SeQuent® Please Neo
JW Medical Systems Ltd
Coronary Artery Disease
01/23
02/25
NCT04982588: Evolut PRO China Clinical Study

Active, not recruiting
N/A
52
RoW
Medtronic CoreValve™ Evolut™ PRO System
Medtronic Cardiovascular
Severe, Symptomatic Aortic Stenosis
03/23
05/28
NCT05580952: Clinical Trial in China

Recruiting
N/A
120
RoW
Transcatheter aortic valve replacement
Genesis Medtech Corporation
Diseases of Aortic Valve, Aortic Regurgitation Disease
05/23
05/24
NCT05607667: Clinical Trial in China for Aortic Valve Stenosis

Recruiting
N/A
53
RoW
Transcatheter aortic valve replacement
Genesis Medtech Corporation
Diseases of Aortic Valve, Aortic Stenosis Disease
05/23
05/23
NCT04722796: HANGZHOU Solution in Bicuspid AS Undergoing TAVR

Recruiting
N/A
508
RoW
TAVR with Venus A plus using supra-annular sizing and THV implantation technique (Hangzhou solution), Hangzhou solution, TAVR with Venus A plus using annular sizing and THV implantation technique, Traditional sizing strategy (Annulus based sizing strategy)
Second Affiliated Hospital, School of Medicine, Zhejiang University, Venus MedTech (HangZhou) Inc., First Affiliated Hospital Bengbu Medical College, Chinese PLA General Hospital, Fujian Medical University Union Hospital, Xiamen University Affiliated Cardiovascular Hospital, Guangdong People's Hospital, Zhengzhou Cardiovascular Hospital, The First Affiliated Hospital of Zhengzhou University, Hennan Provincial Chest Hospital, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Central South University, Northern Jiangsu Province People's Hospital, The First Affiliated Hospital of Nanchang University, Second Affiliated Hospital of Nanchang University, The Affiliated Hospital of Qingdao University, Shanxi cardiovascular hospital, Tianjin Chest Hospital, Ning Bo First Hospital
Aortic Stenosis, Aortic Stenosis With Bicuspid Valve
04/24
04/28

Download Options